Business sector: Supplier of Medicinal Cannabis
Althea is a global pharmaceutical company specialising in the distribution of medicinal cannabis products to several markets including Australia, Germany, the United Kingdom and Ireland. Althea focuses on quality, consistency and continuous supply. Using our extensive expertise, our experienced MSL team work in partnership with healthcare professionals to educate on the clinical usage of medicinal cannabis and simplify pathways for prescribing to optimise clinical outcomes for patients.
ARC Research Hub for Medicinal Agriculture, La Trobe University
Business sector: Research
The Australian Research Council (ARC) Research Hub for Medicinal Agriculture brings together exceptional research capabilities in the fields of agriculture and biomedical sciences, from both Academia and Industry, that will place Australia at the forefront of agribiotech research, production and manufacturing, and enhance the quality of life of all Australians.
AusCann is an Australian company focused on the development and commercialisation of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally. Our key difference is the commitment to rigorous product development, focused on providing reliable, stable and standardised cannabinoid-derived therapeutic solutions to people and pets.
Bridge Product Management
Business sector: Consulting
Bridge Product Management is a consulting business dedicated to providing project management, from new product introduction throughout the product life cycle: sourcing, portfolio management, product and supplier quality management, product certification and compliance.
Cann Group Limited
Business sector: Medicinal Cannabis
Established in 2014, Cann Group is an Australian-based leader in medicinal cannabis with a focus on local cultivation and manufacture of GMP medical products. Our research and development focus aims to deliver enhanced medical cannabis products designed to meet the needs of patients in Australia and around the world. Through ongoing research, and the experience of medical practitioners and patients, we will continue to expand on our product pipeline of unique medical products designed to address specific needs and improve peoples’ quality of life. We currently have a white label product range available for immediate supply within Australia and globally and look forward to discussing your requirements.
Business sectors: Cultivation and Pharma-grade processing
Clever Leaves is a multinational cannabis company emphasizing ecologically sustainable, large-scale cultivation and pharmaceutical-grade processing as the cornerstones of its global cannabis business. With operations and investments in the US, Canada, Colombia, Australia, Germany, and Portugal, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth.
Business sector: Research & Development
CSIRO is Australia’s national science agency and innovation catalyst. We are assisting the medicinal cannabis industry through commercial research projects that span almost the entire product cycle, from providing advice on horticulture and agronomy through to the formulation of prototype cannabis-derived medicines, and almost everything in between.
Cymra Life Sciences
Business sector: Genetics, Propagation Services, Breeding, Tissue
Cymra Life Sciences aims to support Australian growers with all their genetic supply and support services. We can help you with Genetics, Tissue Culture, Breeding services and propagation of clones to your site.
Business Sectors: Regulatory, Pharmacovigilance, Quality consulting services
Enimera RegsPlus is a consultancy company formed around the principles of integrity, innovation, and commercial success.
Our medicinal cannabis clients include biotech and wellness organisations seeking exceptional advice and service for the development and commercialisation of their prescription and consumer medicines.
Epilepsy Action Australia
With over 250,000 people living with epilepsy in this country, Epilepsy Action Australia is leading the way in ensuring those affected have the skills and knowledge to live the very best life possible. We also strive to give parents, teachers, caregivers, support workers, doctors and nurses the confidence, resources and information they need to support their specific needs. Epilepsy Action Australia also helps people living with epilepsy navigate the complex world of medical cannabis. We have developed CanGuide which provides education and support for Health Care Professionals (HCP) such as Doctors and Practice Managers. It also exists to educate and guide people in Australia who may benefit from medical cannabis: people with epilepsy, as well as other conditions such as those experiencing chemotherapy-induced nausea or chronic pain, undergoing palliative care, or living with multiple sclerosis.
Eurofins Chemical Analysis
Business sectors: Analytical Chemistry & Microbiological Testing
Eurofins Chemical Analysis is a TGA licensed testing facility. We offer a full suite of Chemistry and Microbiology Cannabis testing services ie Appearance, ID, Aflatoxins, Ochratoxins, Cannabinoid Profile, Heavy Metals, Microbiology, Pesticides, Terpenes, Stability Studies, Environmental Monitoring, Foreign Matter, Moisture, Ash, Residual Solvents. Contact us for further information.
Frontier Global UW
Business Sector: Insurance & Risk
Frontier Global Underwriting has been created by industry leading professional to provide world class risk transfer and insurance solutions to clients around the globe. The founders and senior management have over sixty years’ combined industry experience, having worked intimately in the markets in which they serve. Frontier is client focussed at its core, founded to improve the quality of the overall service and experience of its clientele. Frontier is an insurer designed around our clients with a true global reach signalling our commitment to the markets we serve. With offices in London and Sydney, Frontier provides 24/7, 365 days a year service to its client base. We are delighted to be supporting the Australian Medicinal Cannabis Industry with our Directors & Officers Liability product offering that we believe will both support directors currently serving on MCIA member boards but also help to assist the industry to attract new independent directors into the sector.
Holmes & Wilson
Business sectors: Consultancy and Advisory Services
Holmes and Wilson is a specialist consultancy dedicated to assisting the Australian medicinal cannabis industry and allied industries navigate the pharmaceutical environment and regulatory standards of development, registration, communication, and supply. We have extensive experience in both pharmaceutical and medicinal cannabis industries so offer a range of advisory services in medical affairs, regulatory affairs, pharmacovigilance and organisational optimisation.
Business sectors: Agriculture/Pharmaceutical
Hydroganics Pty Ltd is a Queensland based licensed cultivator and manufacture of global medicinal cannabis
Intuitive Insurance Solutions
Business Sector: General Insurance Broking
Intuitive is a specialist insurance brokerage providing personal service and tailored solutions to the medicinal cannabis industry. Our aim is to work with our clients to become a trusted advisor and resource to the business, advising on risks apparent and the role insurance can play in managing and minimising those risks.
Business sector: Medicinal Cannabis
Melbourne-based medical cannabis company that aspires to develop cannabis-based medicines for patients suffering from chronic pain and other sports related conditions. With a range of prescription products available under the Levin™ brand accessible through the Special Access Scheme. Our products are made in Australian GMP-certified facilities with Australian cannabis
Mar Verde Consulting
Business Sector: Regulatory consulting
Based in Brisbane, Mar Verde Consulting supports Australian medicinal cannabis licence holders and applicants with regulatory matters, in particular with dealings with the Office of Drug Control. Mar Verde Consulting can help with understanding ODC requirements for licences, variations and permits, with each solution tailored to your needs.
Marsh Pty Ltd
Business sector: Insurance and Risk Advisory
As the Medicinal Cannabis industry grows, the risk landscape continues to evolve. Operating in an industry with a complex regulatory environment, growing consumer demand, and a rapidly changing risk landscape requires a trusted advisor who can identify risks before they emerge. At Marsh, we collaborate with our Medicinal Cannabis clients to understand their business strategy and operational needs and provide a holistic risk assessment. Our local Australian presence and global network enables our Medicinal Cannabis clients to tap into experts that create a customised insurance and risk management plan, fostering the right environment for your business to thrive.
Business sector: Medicinal Cannabis Virtual Clinic
We are a small telehealth only “virtual’ clinic helping eligible patients across Australia, including remote and regional areas, access Medicinal Cannabis therapies, prescriptions and enrolment into clinical trials.
Business sector: Medicinal Cannabis Innovation, unique formulations, research and partnerships.
Medibis are an Australian cultivator, producer, manufacturer, exporter and researcher of high-quality medicinal cannabis products. We are excited to be a part of this industry and are proud to be one of the Australian world leaders in the cultivation and development of medicinal cannabis to support new global treatment methods and quality of life standards. Primarily focusing on the Australian community, we will utilise a vast international community resource log and align this with current research programs to provide end-to-end solutions. Our work will ensure we keep Australia at the forefront of leading-edge technologies
Business sectors: Contract Manufacturer, API and White Label service
MediPharm Labs is a fully licensed B2B contract manufacturer offering pharmaceutical-grade cannabinoid preparations and API. The company’s Australian facility is TGA-GMP certified for API a range of finished dose formats.
MedReleaf Australia is licensed to cultivate, import, warehouse and manufacture medical cannabis by the Federal Government’s Office of Drug Control (ODC). The company has a strategic partnership with Aurora Cannabis Enterprises and is backed by more than 40 years of pharmaceutical and healthcare expertise, driven by research and product development, and is striving to make improvements to the health of Australian patients.
We dedicate ourselves to innovation and operational excellence. A distinct business positioned to take advantage of a rapidly growing market built to service the Australian medical industry including Doctors, Pharmacists and allied health professionals
Business sectors: Cultivation, Manufacturing, Research, Commercialisation
MedTEC Pharma was founded to lead the medicinal cannabis industry on a path to delivering an evidence-based medicine; trusted by health professionals and accessible by those needing relief from chronic conditions. Our vision is to provide naturally grown, safe and accessible products to improve the quality of life of patients.
Merck Pty Ltd
Business Sector: Life Science
Merck offers a comprehensive selection of analytical tools to promote safety of cannabis products, including testing workflows for analysis of terpenes, cannabinoids, pesticides, mycotoxins, heavy metals, and residual solvents. We also empower scientists in R&D tissue culture & breeding, proteomics, genomics, CRISPR, and soil & water analysis to deliver breakthroughs faster.
Business Sector: Medicinal Cannabis Supply and Distribution
Provocatus is an Australian Veteran Owned medicinal cannabis supply and distribution company. We strive to become a market leader in Australia by delivering high quality, GMP certified products. Provocatus believes in accessible treatment for all Australians suffering eligible conditions, and has a particular interest in the healthcare of ADF Veterans.
SatiVite Group Limited
Business sector: Medicinal Cannabis Wholesaler
Headquartered in Bellbowrie, Australia, Sativite is a licensed medical cannabis wholesaler. We seek out, import and distribute premium medicinal cannabis – selected varieties of high-quality, organically and sustainably grown dried flower and broad-spectrum extracts and oils with a range of cannabinoid profiles, as well as innovative cannabis-based medicines and delivery devices from leading licensed suppliers worldwide.
Business sector: Manufacturing Equipment
Scitek has 30 years pharmaceutical industry experience in providing high-end technologies for natural product processing and has been active in cannabis since legalisation. Our technologies include drying, extraction, post processing, isolation, formulation and much more. We are exclusive Premium Distributors for globally leading cannabis brands including Enwave, Devex, Precision Extraction, MRXxtractors, Cascade, Asahi, Heidolph and Vacuubrand. Scitek’s focus is on providing honest cannabis production technology consulting, equipment supply and benchmark service. Scitek products comply with applicable ASNZ standards and are GMP ready.
Business sector: Cultivator / GMP Certified Producer
Our company is an Australian operated medicinal cannabis cultivation and production facility based in Tasmania. We are AU-GMP licenced to produce oral liquids and dried herb products for inhalation under the Tasmanian Botanics brand.
Business sector: Pharmaceuticals
Tilray is the first GMP-certified medical cannabis producer to supply cannabis extract products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers on four continents. Tilray Australia and New Zealand is dedicated to supporting healthcare professionals and patients in the region with access to our medicinal cannabis products. We supply our products to government and hospital clients as well as to leading pharmacies across Australia.
Zelira Therapeutics Ltd is a leading global biopharmaceutical company manufacturing and marketing cannabinoid-based medicines. Zelira owns a portfolio of proprietary revenue generating products and a pipeline of candidates undergoing clinical development that are positioned to access the world’s largest and fastest growing markets.